Interferon-alpha, bcl-2 expression and apoptosis in B-cell chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 21, Issue 1-2, 1996, Pages 43-47

  Jewell, A P ^a  

^a KINGSTON UNIVERSITY   (United Kingdom)

Author keywords

Apoptosis; B CLL; bcl 2; Interferon alpha

Indexed keywords

ALPHA INTERFERON; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6;

APOPTOSIS; B LYMPHOCYTE; BLOOD; BONE MARROW; CELL CULTURE; CELL SURVIVAL; CHRONIC LYMPHATIC LEUKEMIA; DRUG MECHANISM; GENE EXPRESSION REGULATION; HUMAN; LEUKEMIA REMISSION; ONCOGENE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0029670782     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199609067578     Document Type: Review

References (48)

1. De Maeyer, E. and De Maeyer-Guignard, J. (1988) Interferons and other regulatory cytokines. John Wiley & Sons New York.
2. Goldstein, D. and Laszlo, J. (1986) Interferon therapy in cancer: from imagination to Interferon. Cancer Research, 46, 4315-4329.
3. Quesada, J. R., Reuben, J., Manning, J. T., Hersh, E. M., and Gutterman, J. U. (1984) Alpha Interferon for the induction of remission in hairy cell leukemia. New England Journal of Medicine, 310, 15-18.
4. Galvani, D. W. and Cawley, J. C. (1990) The current status of interferon-alpha in haemic malignancy. Blood Reviews, 4, 175-180.
5. Heslop, H. E. and Hoffbrand, A. V. (1992) Interferons in haematological malignancy. Recent Advances in Haematology, 7, 131-148.
6. Foon, K. A., Bottino, G. C., Abrams, P. G., Fer, M. F., Longo, D. L., Schoenberger, C. S., and Oldham, R. K. (1985) Phase II trial of recombinant leukocyte A Interferon in patients with advanced chronic lymphocytic leukemia. American Journal of Medicine, 78, 216-220.
7. Pangalis, G. A. and Griva, E. (1988) Recombinant alfa 2b interferon therapy in untreated stages A and B chronic lymphocytic leukemia. Cancer, 61, 869-872.
8. Rozman, C., Montserrat, E., Vinolas, N., Urbano-Ispizua, A., Ribera, J. M., Gallart, T., and Compernolle, C. (1988) Recombinant alpha 2 interferon in the treatment of chronic lymphocytic leukemia in early stages. Blood, 71, 1355-1360.
9. McSweeney, E. N., Giles, F. J., Worman, C. P., Jewell, A. P., Tsakona, C. P., Hoffbrand, A. V., Mehta, A. B., Newland, A. C., and Goldstone, A. H. (1993) Recombinant alfa 2a interferon therapy in the treatment of patients with early stage B chronic lymphatic leukaemia. British Journal of Haematology, 85, 77-83.
10. Heslop, H. E., Bianchi, A. C. M., Cordingley, F. T., Turner, M., De Mel, C. P., Hoffbrand, A. V., and Brenner, M. K. (1990) Effects of interferon-alpha on autocrine growth factor loops in B lymphoproliferative disorders. Journal of Experimental Medicine, 172, 1729-1734.
11. Hoffbrand, A. V., Panayiotidis, P., Reittie, J., and Ganeshaguni, K. (1993) Autocrine and paracrine growth loops in chronic lympho-cytic leukemia. Seminars in Haematology, 30, 306-317.
12. Ostlund, L., Einhorn, S., Robert, K-H., Juliusson, G., and Biberfeld, P. (1985) Chronic B-lymphocytic leukaemia cells proliferate and differentiate following exposure to interferon in vitro. Blood, 67, 152-159.
13. Drexler, H. G. (1988) Which cells do respond during in vitro stimulation of B-CLL and HCL cultures? Leukaemia, 4, 240-241.
14. Totterman, T., Carlsson, M., and Nilsson, K. (1988) Induction of IgM secretion in chronic lymphocytic leukaemia cells in serum free medium: Effects on interferon-alpha, -gamma and phorbol ester. Clinical and Experimental Immunology, 71, 187-192.
15. Nossal, G. V. (1983) Cellular mechanisms of immunologic tolerance. Annual Review of Immunology, 1, 33-62.
16. Jewell, A. P., Yong, K. L., Worman, C. P., Giles, F. J., Goldstone, A. H., and Lydyard, P. M. (1992) Cytokine induction of leucocyte adhesion molecule-1 (LAM-1) on chronic lymphocytic leukaemia cells. Leukaemia, 6, 400-404.
17. Jewell, A. P., Yong, K. L., Worman, C. P., Tsakona, C. P., Giles, F. J., and Goldstone, A. H. (1994) Serum macrophage colony stimulating factor (M-CSF) levels correlate with clinical response to interferon-alpha in patients with early stage B-CLL. British Journal of Haematology, 86, 441-443.
18. Jewell, A. P., Worman, C. P., Giles, F. J., Goldstone, A. H., and Lydyard, P. M. (1992) Resistance of chronic lymphocytic leukaemia cells to interferon-alpha generated lymphokine activated killer cells. Leukaemia and Lymphoma, 7, 473-480.
19. Tsujimoto, Y., Cossman, J., Jaffe, E, and Croce, C. M. (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science, 228, 1440-1443.
20. Cohen, J. J. (1991) Programmed cell death in the immune system. Advances in Immunology, 50, 55-85.
21. McDonnell, T. J., Deane, N., Platt, F. M., Nunez, G., Jaeger, U., McKearn, J. P., and Korsmeyer, S. J. (1989) Bcl-2-immunoglobulin transgenic mice demonstrate extended B-cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
22. Dighiero, G. (1993) Biology of the neoplastic lymphocyte in B-CLL. Baillieres Clinical Haematology, 6, 807-820.
23. Raghobier, S., van Kreiken, J. H. J. M., Kluin-Nelemans, J. C.,Gillis, A., van Ommen, G. J. B., Ginsberg, A. M., Raffeld, M., and Kluin, P. M. (1991) Oncogene rearrangements in chronic B-cell leukemia. Blood, 77, 1560-1564.
24. Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., and Mason, D. Y. (1990) Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. American Journal of Pathology, 137, 225-232.
25. Hanada, M., Delia, D., Aiello, A., Stadtmauer, E., and Reed, J. C. (1993) bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia. Blood, 82, 1820-1828.
26. Liu, Y. J., Johnson, G. D., Gordon, J., and MacLennan, I. C. M. (1992) Germinal centres in T-cell-dependent antibody responses. Immunology Today, 13, 17-21.
27. Schena, M., Gottardi, D, Ghia, P., Larsson, L-G., Carlsson, M., Nilsson, K., and Caligaris-Cappio, F. (1993) The role of bcl-2 in the pathogenesis of B chronic lymphocytic leukemia. Leukemia and Lymphoma, 11, 173-179.
28. Jonak, G. J. and Knight, E. (1987) Interferons and the regulation of oncogenes. Interferon, 8, 167-180.
29. Foon, K. A., Rai, K. R., and Gale, R. P. (1990) Chronic lymphocytic leukaemia: new insights into biology and therapy. Annals of Internal Medicine, 113, 525-539.
30. Collins, R. J., Verschuer, L. A., Harmon, B. V., Prentice, R. L., Pope, J. H., and Kerr, J. F. R. (1989) Spontaneous programmed cell death (apoptosis) of B-chronic lymphocytic leukaemia cells following their culture in vitro. British Journal of Haematology, 71, 343-350.
31. Nunez, G., London,L., Hockenbury, D., Alexander, M., McKearn, J. P., and Korsmeyer, S. J. (1990) Deregulated bcl-2 expression selectively prolongs survival of growth factor dependent hemopoietic cell lines. Journal of Immunology. 144, 3602-3610.
32. Jewell, A. P., Lydyard, P. M., Worman, C. P., Giles, F. J., and Goldstone, A. H. (1994) Growth factors can protect B-chronic lymphocytic leukemia cells against programmed cell death without stimulating proliferation. Leukemia and Lymphoma,
33. Huang, R. W., Tsuda, H., and Takatsuki, K. (1993) Interleukin-2 prevents programmed cell death in chronic lymphocytic leukemia cells. International Journal of Hematology, 58, 83-92.
34. Danescu, M., Rubio-Trujillo, M., Biron, G., Delespesse, G., and Sarfati, M. (1992) Interleukin 4 protects chronic lymphocytic leukemia cells from death by apoptosis and Lip-regulates bcl-2 expression. Journal of Experimental Medicine, 176, 1319-1326.
35. Panayiotidis, P., Gareshaguru, K., Jabbar, S. A., and Hoffbrand, A. V. (1993) Interleukin 4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukemia cells in vitro. British Journal of Haematology, 85, 439-445.
36. Buschle, M., Campana, D., Carding, S. R., Richard. C., Hoffbrand, A. V., and Brenner, M. K. (1993) Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. Journal of experimental Medicine, 177, 213-218.
37. Panayiotidis, P., Ganeshaguru, K., Jabbar, S. A., and Hoffbrand, A. V. (1994) Alpha interferon protects B-chronic lymphocytic leukemia cells from apoptotic cell death in vitro. British Journal of Haematology, 86, 169-173.
38. Jewell, A. P., Worman, C. P., Lydyard, P. M., Yong, K. L., Giles, F. J., and Goldstone, A. H. (1994) Interferon alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. British Journal of Haematology, 88, 268-274.
39. Chaouchi, N., Wallon, C., Taieb, J., Auffredou, M. T. Tertian, G., Lemoine, F. M., Delfraissy, J. F., and Vazquez, A. (1994) Interferon-alpha mediated prevention of in vitro apoptosis of chronic lymphocytic leukaemia cells:role of bcl-2 and c-myc. Clinical Immunology and Immunopathology, 73, 197-204.
40. Nunez, C. and Clarke, M. F. (1994) The bcl-2 family of proteins; regulators of cell death and survival. Trends in Cell Biology, 4, 399-403.
41. Kipps, T. J., Rassenti, L. Z., Duffy, S., Kobayashi, R., Martin, T., Chen, P, P., and Carson, D. A. (1991) Immunoglobulin gene rearrangement and expression in B-CLL. Leukaemia and lymphoma, 5 S1, 39-45.
42. MacLennan, I. C. M. and Gray, D. (1986) Antigen driven selection of virgin and memory B-cells. Immunological Reviews, 91, 61-86.
43. Ihle, J. N. and Kerr, I. M. (1995) Jaks and stats in signalling by the cytokine receptor family. Trends in Genetics, 11, 69-74.
44. Xu, B., Grander, D., Sangfelt, O., and Einhorn, S. (1994) Primary leukaemia cells resistant to alpha-interferon in vitro are defective in the activation of the DNA binding factor interferon-stimulated gene factor 3. Blood. 84, 1942-1949.
45. Fluckiger, A. C., Durand, I., and Banchereau, J. (1994) Interleukin 10 induces apoptotic cell death of B-chronic lymphocytic leukemia cells. Journal of Experimental Medicine, 179, 91-99.
46. Briere, F., Bridon, J. M., Chevet, D., Souillet, G., Bienvenu, F., and Guret, C. (1994) Interleukin 10 induces B lymphocytes from IgA deficient patients to secrete IgA. Journal of Clinical Investigation, 94, 97-104.
47. Mainou-Fowler, T., Craig, V. A., Copplestone, J. A., Hamon, M. D., and Prentice, A. G. (1994) Interleukin 5 increases spontaneous apoptosis of B-cell chronic lymphocytic leukaemia cells in vitro independently of bcl-2 expression and is inhibited by IL-4. Blood, 84, 2297-2304.
48. Jewell, A. P. and Khwaja, A. (1994) Unpublished observations.